Researchers at the Centre for Genomic Regulation (CRG), in collaboration with the Institute for Research in Biomedicine (IRB Barcelona) at PCB, developed a new method to systematically identify genes contributing to heritable cancer risk.The study, published in Nature Communications, is a success story for data sharing and openness in science.
An international study published in the journal Molecular Psychiatry has identified forty genes related to aggressive behaviour in humans and mice. Participants in the study, which could contribute to shape future pharmacological targets, are the researchers Bru Cormand and Noèlia Fernàndez Castillo, from the Faculty of Biology at the University of Barcelona and the Institute of Biomedicine of the UB (IBUB), present at the Barcelona Science Park.
Scientists from Eugin’s Basic Research Laboratory at the Barcelona Science Park and the Microtubule Function and Cell Division group of the Centre for Genomic Regulation (CRG) have succeeded in identifying 288 proteins found in human sperm and which are key for the formation of the zygote and the subsequent development of the embryo. The results of this research are to be presented at the 34th Annual Meeting of ESHRE, the European Society of Human Reproduction and Embryology, which takes place in Barcelona from July 1 to 4.
Today, Monday 2 July, the Barcelona Science Park (PCB) has kicked off its 18th Research in Society programme with the opening of the pre-registration period for the experimental workshops “Discover research!” and “Do research!”. Places will be allocated to applicant schools in a draw using the list of reservation numbers.
Psychiatric disorders share a great genetic subsceptibility, while non-psychiatric neurological disorders –such as Alzheimer’s and Parkinson’s- have a more specific genetic, according to an article the journal Science has published. The work is the most ambitious and extense on shared genetic factors in brain disorders. In this multicentre study –driven by Verneri Anttila, Aiden Corvi and Ben Neale from the Brainstorm Consortium– participate the lecturers Bru Cormand and Raquel Rabionet, from the Faculty of Biology and members of the Institute of Biomedicine of the UB (IBUB) in the Barcelona Science Park, among more than 500 experts from around the world.
Catalan biomedical companies attracted €102 million in investment in 2017, with €3.4 million per operation, on average. This will allow them to push forward in the development of drugs and innovative medical technology, as reflected in the Study on investment in the Biomedical industry in Catalonia: Achievements and future challenges presented by CataloniaBio & HealthTech, based in Barcelona Science Park, and EY on Tuesday at the Círculo de Economía in Barcelona. The event drew a crowd of more than 60 entrepreneurs, investors and professionals from the sector.
The Genesis Ventures fund—managed by the consultancy firm Genesis Biomed headquartered in the Barcelona Science Park—has secured its first deal with its investment of €75,000 in the NeuroHeal project, a new pharmacological combination that accelerates nerve regeneration, developed at the Neurosciences Institute (INc) of the Autonomous University of Barcelona (UAB).
Laboratorios Ordesa head up the TOLERA consortium, which was conceived with the aim of developing workable solutions for the food industry that provide safer and more effective foodstuffs and ingredients to prevent people from developing food intolerances and allergies. Under the framework of this project—driven by the Centre for the Development of Industrial Technology (CDTI) with a budget of €8.1 million for the 2018-2021 period—the company will promote various research studies, both their own at their research centre in Barcelona Science Park, and in partnership with other companies, universities and public and private R&D centres.
One more year, the Barcelona Science Park (PCB) participates in BIO International Convention, the largest global event for the biotech and pharmaceutical sector hosted annually by the Biotechnology Industry Organization (BIO). This year the meeting will take place from 4 to 7 June in Boston (Massachusetts, United States) and is expected to attract more than 16,000 attendees from 74 countries. The Catalan delegation makes up half of all of the Spanish companies participating in the fair, with 38 companies and organizations, nine of which are based in PCB.
The research group of ICREA professor Xavier Trepat at IBEC in PCB revelals that cell division in epithelial tissues is regulated by mechanical forces Thie study, published in Nature Cell Biology, could potentially opening avenues to a greater understanding of the uncontrolled proliferation of cancer cells in tumors, and their possible regulation by means of physical forces.
